ijms-logo

Journal Browser

Journal Browser

Research on Dynamic Interaction of Matricellular Proteins and Their Receptors

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Biology".

Deadline for manuscript submissions: closed (15 August 2023) | Viewed by 3668

Special Issue Editors


E-Mail Website
Guest Editor
Institute for Genetic Medicine, Division of Molecular Psychoimmunology, Hokkaido University, Sapporo 060-0815, Japan
Interests: osteoponitn; Tenascin-C; integrin; autoimmune disease; chronic inflammation

E-Mail Website
Guest Editor
Department of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Gakuen-cho 1, Fukuyama, Hiroshima, Hiroshima 729-0292, Japan
Interests: nephronectin; osteopontin; integrin; EAE; post-translational modification
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

We are delighted to introduce this Special Issue of International Journal of Molecular Sciences, which features a series of commissioned articles on Research on Dynamic Interaction of Matricellular Proteins and Their Receptors. Extracellular matrix proteins (ECM) are constitutively expressed as essential structural components of organs and tissues and contribute to the morphological and functional integrity of organs and tissues. Within classical ECM, there are a unique group of molecules that are different from classical ECM in many ways. These are matricellular proteins. Matricellular proteins are not constitutively expressed in the body, but transiently expressed during specific embryonic stages and in pathological and physiological conditions. Matricellular proteins can be exist as soluble proteins rather than structural components. Osteopontin, tenascin-c, periostin, CCN family members, thrombospondin-1, and many other molecules are now classified as matricellular proteins. Matricellular proteins contain many cellular binding domains, including hidden binding domains that can be exposed after protease cleavage and can bind to more than single cellular receptors, including integrins. Thus, components of tissue microenvironments such as proteases, pathogens, inflammation, and cell types are critical functional modifiers of matricellular proteins. The complex but tightly regulated interaction between matricellular proteins and their receptor leads to divergent physiological and pathological consequences in many organs and tissues. Authors are invited to review recent publications or submit original studies on Interactions of Matricellular Proteins and Their Receptors.

Prof. Dr. Toshimitsu Uede
Prof. Dr. Shigeyuki Kon
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • matricellular proteins
  • integrin
  • autoimmune diseases
  • cardiovascular diseases
  • respiratory diseases
  • immunology
  • neurological disease
  • cancer

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

19 pages, 2216 KiB  
Article
CD47-Dependent Regulation of Immune Checkpoint Gene Expression and MYCN mRNA Splicing in Murine CD8 and Jurkat T Cells
by Sukhbir Kaur, Duha Awad, Richard P. Finney, Thomas J. Meyer, Satya P. Singh, Margaret C. Cam, Baktiar O. Karim, Andrew C. Warner and David D. Roberts
Int. J. Mol. Sci. 2023, 24(3), 2612; https://doi.org/10.3390/ijms24032612 - 30 Jan 2023
Cited by 1 | Viewed by 3031
Abstract
Elevated expression of CD47 in some cancers is associated with poor survival related to its function as an innate immune checkpoint when expressed on tumor cells. In contrast, elevated CD47 expression in cutaneous melanomas is associated with improved survival. Previous studies implicated protective [...] Read more.
Elevated expression of CD47 in some cancers is associated with poor survival related to its function as an innate immune checkpoint when expressed on tumor cells. In contrast, elevated CD47 expression in cutaneous melanomas is associated with improved survival. Previous studies implicated protective functions of CD47 expressed by immune cells in the melanoma tumor microenvironment. RNA sequencing analysis of responses induced by CD3 and CD28 engagement on wild type and CD47-deficient Jurkat T lymphoblast cells identified additional regulators of T cell function that were also CD47-dependent in mouse CD8 T cells. MYCN mRNA expression was upregulated in CD47-deficient cells but downregulated in CD47-deficient cells following activation. CD47 also regulated alternative splicing that produces two N-MYC isoforms. The CD47 ligand thrombospondin-1 inhibited expression of these MYCN mRNA isoforms, as well as induction of the oncogenic decoy MYCN opposite strand (MYCNOS) RNA during T cell activation. Analysis of mRNA expression data for melanomas in The Cancer Genome Atlas identified a significant coexpression of MYCN with CD47 and known regulators of CD8 T cell function. Thrombospondin-1 inhibited the induction of TIGIT, CD40LG, and MCL1 mRNAs following T cell activation in vitro. Increased mRNA expression of these T cell transcripts and MYCN in melanomas was associated with improved overall survival. Full article
Show Figures

Figure 1

Back to TopTop